⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRS News
Aclaris Therapeutics, Inc.
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com
ACRS
Huntress and Acrisure Announce New Cyber Insurance Program with No Deductible for Eligible Applicants
globenewswire.com
ACRS
Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference
globenewswire.com
ACRS
Acres.com Launches Acres Intelligence, the First AI Agent Built for Land Teams
globenewswire.com
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update
globenewswire.com
ACRS
Alcresta Therapeutics Announces Preclinical Data Evaluating RELiZORBneo Cartridge Use in Neonatal Murine Model of Necrotizing Enterocolitis
prnewswire.com
ACRS
Form 8-K
sec.gov
ACRS
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indication
globenewswire.com
ACRS